We are live on
!
Find out more
First Manhattan Portfolio holdings
AUM
$36.1B
1-Year Est. Return
11.5%
This Fund
S&P 500
This Quarter
Est. Return
-0.07%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$27.1B
AUM Growth
-$250M
(-0.91%)
Cap. Flow
+$8.92M
Cap. Flow
% of AUM
0.03%
Top 10 Holdings %
Top 10 Hldgs %
55.27%
Holding
1,748
New
132
Increased
271
Reduced
387
Closed
93
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPLI
People Inc
PPLI
|
+$92.9M |
| 2 |
Amazon
AMZN
|
+$62.6M |
| 3 |
Enanta Pharmaceuticals
ENTA
|
+$46.3M |
| 4 |
VMEO
Vimeo
VMEO
|
+$33.1M |
| 5 |
UnitedHealth
UNH
|
+$28M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$49.9M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
+$43.5M |
| 3 |
Humana
HUM
|
+$36.6M |
| 4 |
Vipshop
VIPS
|
+$35.6M |
| 5 |
Brookfield
BN
|
+$24M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 41.6% |
| 2 | Technology | 16.13% |
| 3 | Healthcare | 10.46% |
| 4 | Consumer Discretionary | 9.11% |
| 5 | Communication Services | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Berkshire Hathaway Class A
BRK.A
$1.06T
| $7.69B | 28.35% |
18,704
-103
| -0.5% | -$43.5M |
|
2
Microsoft
MSFT
$2.83T
| $1.44B | 5.32% |
5,125,099
-17,420
| -0.3% | -$5.07M |
|
3
Apple
AAPL
$4.72T
| $1.42B | 5.22% |
10,016,970
+15,156
| +0.2% | +$2.23M |
|
|
4
Brookfield
BN
$101B
| $910M | 3.35% |
31,558,680
-821,817
| -3% | -$24M |
|
5
Alphabet (Google) Class C
GOOG
$3.88T
| $704M | 2.59% |
5,281,380
+29,500
| +0.6% | +$4.07M |
|
6
Danaher
DHR
$135B
| $649M | 2.39% |
2,405,029
-31,860
| -1% | -$8.67M |
|
|
7
UnitedHealth
UNH
$385B
| $611M | 2.25% |
1,562,853
+67,535
| +5% | +$28M |
|
|
8
Berkshire Hathaway Class B
BRK.B
$1.06T
| $597M | 2.2% |
2,188,615
-8,841
| -0.4% | -$2.48M |
|
|
9
Amazon
AMZN
$2.51T
| $494M | 1.82% |
3,006,340
+362,720
| +14% | +$62.6M |
|
|
PPLI
10
People Inc
PPLI
$3.14B
| $481M | 1.77% |
4,499,439
+843,347
| +23% | +$92.9M |
|
11
AutoZone
AZO
$47.7B
| $461M | 1.7% |
271,381
+3,681
| +1% | +$5.9M |
|
12
KKR & Co
KKR
$86.2B
| $408M | 1.5% |
6,694,827
+301,801
| +5% | +$19M |
|
13
Meta Platforms (Facebook)
META
$1.54T
| $388M | 1.43% |
1,143,007
+55,384
| +5% | +$19.9M |
|
14
Thermo Fisher Scientific
TMO
$213B
| $364M | 1.34% |
637,905
+2,789
| +0.4% | +$1.53M |
|
15
Oracle
ORCL
$346B
| $355M | 1.31% |
4,079,529
-56,785
| -1% | -$5.02M |
|
16
Johnson & Johnson
JNJ
$624B
| $300M | 1.11% |
1,859,343
-34,000
| -2% | -$5.8M |
|
17
Honeywell
HON
$78B
| $285M | 1.05% |
1,425,153
-14,800
| -1% | -$3.15M |
|
18
Visa
V
$669B
| $271M | 1% |
1,217,483
-12,192
| -1% | -$2.86M |
|
19
Accenture
ACN
$84.9B
| $257M | 0.95% |
804,019
-22,479
| -3% | -$7.31M |
|
20
Comcast
CMCSA
$78.3B
| $254M | 0.94% |
4,547,925
+129,911
| +3% | +$7.58M |
|
21
PayPal
PYPL
$49.4B
| $238M | 0.88% |
915,556
+28,839
| +3% | +$8.18M |
|
22
Keysight
KEYS
$55.6B
| $228M | 0.84% |
1,385,265
-8,072
| -0.6% | -$1.35M |
|
|
23
Alphabet (Google) Class A
GOOGL
$3.88T
| $222M | 0.82% |
1,660,120
+140
| +0% | +$19.1K |
|
24
GoDaddy
GDDY
$11.6B
| $211M | 0.78% |
3,020,395
+350,311
| +13% | +$27.1M |
|
|
IAA
25
DELISTED
IAA, Inc. Common Stock
IAA
| $196M | 0.72% |
3,595,619
-277,706
| -7% | -$15.4M |
|
Similar funds
SAM
First Manhattan's Q3 2021 Portfolio in Review
As of Q3 2021, First Manhattan held 1,748 positions worth $27.1B, down 0.91% from $27.4B the previous quarter. Its ten largest holdings account for 55% of the portfolio.
First Manhattan's Q3 2021 filing shows 132 new, 271 increased, 387 reduced and 93 closed positions. Its largest new stake was Immunocore: 197,999 shares worth $7.34M. The largest sale was Amgen, an estimated $49.9M.
By sector, the portfolio is most concentrated in Financials at 42% of assets, down from 42% a quarter earlier, followed by Technology and Healthcare.
- First Manhattan's largest Q3 2021 buy was Immunocore: 197,999 shares worth $7.34M.
- First Manhattan added most to People Inc in Q3 2021, an estimated $92.9M increase.
- First Manhattan's biggest Q3 2021 reduction was Amgen, cutting an estimated $49.9M.
- First Manhattan fully exited Humana in Q3 2021, selling an estimated $36.6M.
- First Manhattan's ten largest holdings make up 55% of its $27.1B portfolio in Q3 2021.
- First Manhattan opened 132 new positions and closed 93 in Q3 2021.
- First Manhattan's portfolio value fell 0.91% quarter-over-quarter to $27.1B.
Based on First Manhattan's 13F filing for Q3 2021, filed 15 Nov 2021.